AETERNA ZENTARIS INC/ CA0079756007 /
23/05/2024 21:57:59 | Chg. - | Volume | Bid22:00:40 | Ask22:00:40 | High | Low |
---|---|---|---|---|---|---|
11.69CAD | - | 314 Turnover: 3,488 |
11.45Bid Size: 100 | 12.00Ask Size: 100 | 11.69 | 11.59 |
GlobeNewswire
27/03
Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completio...
GlobeNewswire
12/03
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
GlobeNewswire
12/03
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
GlobeNewswire
26/02
Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders V...
GlobeNewswire
26/02
Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders V...
GlobeNewswire
23/02
Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceu...
GlobeNewswire
15/02
Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Sec...
GlobeNewswire
15/02
Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meetin...
GlobeNewswire
14/12/2023
Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Comp...
GlobeNewswire
11/10/2023
Aeterna Zentaris to Participate at the Virtual Investor Ask the CEO Conference
GlobeNewswire
05/09/2023
Aeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire
29/03/2022
Aeterna Zentaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business O...
GlobeNewswire
21/03/2022
Aeterna Zentaris Provides Update on Ongoing Pivotal Phase 3 DETECT-Trial for the Diagnosis of Childh...
GlobeNewswire
10/03/2022
Aeterna Zentaris Announces Expansion of Research Program with Julius-Maximilians-University Wuerzbur...